| ID | 1504 | |
| PMID | 15603887 | |
| Year | 2005 | |
| Sequence | DLPVLQLTDPPGVRRV YHIQAGLPDPFQPPS | |
| Name | gD 22-52 (group 1) | |
| Length | 31 | |
| N-Terminal Modification | Free | |
| C-Terminal Modification | Free | |
| Linear/ Cyclic | Linear | |
| Chirality | L | |
| Chemical Modification | None | |
| Origin of Peptide | T-cell epitope peptide identified from HSV1-gD | |
| Nature of Peptide/Cargo | not mentioned | |
| Mechanism | T-cell epitope peptide identified from HSV1-gD | |
| Cargo Sequence/Structure | None | |
| Name of cargo | Not applicable | |
| Assay | ELISA, Antibody assay, Peptide specific T-cell assays | |
| Enhancer | PBS (pH 7.3). | |
| Properties of enhancer | Not mentioned | |
| Concentration | 25ul | |
| Incubation time | 21 days | |
| Tissue permeability (value with units) | Induced higher IgA response. | |
| Tissue Sample | eye | |
| Ex vivo/In vivo/In vitro | in vivo | |
| STRUCTURE |
| |
| SMILES | N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H] (C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H] (C(=O)N2[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N [C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H] (C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O) N[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H] (C(=O)N[C@H](C=O)CO)CCC)CCC)CCC(=O)N)Cc4ccccc4)CCC3) CC(=O)O)CCC)CC(C)C)C)CCC(=O)N)[C@H](CC)C) Cc3[nH]cnc3)Cc3ccc(cc3)O)C(C)C)CCCNC(=N)N)CCCNC(=N)N)C(C)C)CCC) CCC2)CC(=O)O)[C@H](O)C)CC(C)C)CCC(=O)N)CC (C)C)C(C)C)CCC1)CC(C)C)CC(=O)O | |